Active IBD and experimental colitis are associated with the expression and secretion of many pro-inflammatory cytokines, including IL-1β, TNF-α, IL-6, IFN-γ and IL-17 by innate and adaptive immune cells [3,23]. This evidence concerns the gene IL17A and inflammatory bowel disease.